The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 12 10 2020
accepted: 18 01 2021
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 7 2 2021
Statut: epublish

Résumé

The overall global impact of COVID-19 in children and regional variability in pediatric outcomes are presently unknown. To evaluate the magnitude of global COVID-19 death and intensive care unit (ICU) admission in children aged 0-19 years, a systematic review was conducted for articles and national reports as of December 7, 2020. This systematic review is registered with PROSPERO (registration number: CRD42020179696). We reviewed 16,027 articles as well as 225 national reports from 216 countries. Among the 3,788 global pediatric COVID-19 deaths, 3,394 (91.5%) deaths were reported from low- and middle-income countries (LMIC), while 83.5% of pediatric population from all included countries were from LMIC. The pediatric deaths/1,000,000 children and case fatality rate (CFR) were significantly higher in LMIC than in high-income countries (HIC) (2.77 in LMIC vs 1.32 in HIC; p < 0.001 and 0.24% in LMIC vs 0.01% in HIC; p < 0.001, respectively). The ICU admission/1,000,000 children was 18.80 and 1.48 in HIC and LMIC, respectively (p < 0.001). The highest deaths/1,000,000 children and CFR were in infants < 1 year old (10.03 and 0.58% in the world, 5.39 and 0.07% in HIC and 10.98 and 1.30% in LMIC, respectively). The study highlights that there may be a larger impact of pediatric COVID-19 fatality in LMICs compared to HICs.

Sections du résumé

BACKGROUND
The overall global impact of COVID-19 in children and regional variability in pediatric outcomes are presently unknown.
METHODS
To evaluate the magnitude of global COVID-19 death and intensive care unit (ICU) admission in children aged 0-19 years, a systematic review was conducted for articles and national reports as of December 7, 2020. This systematic review is registered with PROSPERO (registration number: CRD42020179696).
RESULTS
We reviewed 16,027 articles as well as 225 national reports from 216 countries. Among the 3,788 global pediatric COVID-19 deaths, 3,394 (91.5%) deaths were reported from low- and middle-income countries (LMIC), while 83.5% of pediatric population from all included countries were from LMIC. The pediatric deaths/1,000,000 children and case fatality rate (CFR) were significantly higher in LMIC than in high-income countries (HIC) (2.77 in LMIC vs 1.32 in HIC; p < 0.001 and 0.24% in LMIC vs 0.01% in HIC; p < 0.001, respectively). The ICU admission/1,000,000 children was 18.80 and 1.48 in HIC and LMIC, respectively (p < 0.001). The highest deaths/1,000,000 children and CFR were in infants < 1 year old (10.03 and 0.58% in the world, 5.39 and 0.07% in HIC and 10.98 and 1.30% in LMIC, respectively).
CONCLUSIONS
The study highlights that there may be a larger impact of pediatric COVID-19 fatality in LMICs compared to HICs.

Identifiants

pubmed: 33513204
doi: 10.1371/journal.pone.0246326
pii: PONE-D-20-31841
pmc: PMC7845974
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0246326

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dev Ctries. 2020 Feb 29;14(2):125-128
pubmed: 32146445
Lancet Infect Dis. 2020 Jul;20(7):776-777
pubmed: 32224313
Case Rep Pediatr. 2020 Sep 24;2020:8847415
pubmed: 33014499
BMC Med. 2014 Feb 04;12:19
pubmed: 24495839
Intensive Care Med. 2014 Mar;40(3):342-52
pubmed: 24337401
Int J Environ Res Public Health. 2016 Jul 07;13(7):
pubmed: 27399740
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Indian J Pediatr. 2020 Sep;87(9):757-758
pubmed: 32548735
J R Soc Med. 2013 Oct;106(10):408-14
pubmed: 23824332
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
JAMA Pediatr. 2020 Sep 1;174(9):882-889
pubmed: 32320004
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1324-1329
pubmed: 32941417
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Emerg Infect Dis. 2020 Jun;26(6):1339-1441
pubmed: 32168463
PLoS One. 2015 Jan 24;10(1):e0116949
pubmed: 25617837

Auteurs

Taito Kitano (T)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Mao Kitano (M)

Mikage Child Dental Clinic, Kobe, Hyogo, Japan.

Carsten Krueger (C)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Hassan Jamal (H)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Hatem Al Rawahi (H)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Rachelle Lee-Krueger (R)

Faculty of Education, University of Ottawa, Ottawa, ON, Canada.

Rose Doulin Sun (RD)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Sandra Isabel (S)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Marta Taida García-Ascaso (MT)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Hiromi Hibino (H)

McEwen Stem Cell Institute, Universal Health Network, Toronto, ON, Canada.

Bettina Camara (B)

Faculty of Immunology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Marc Isabel (M)

Département de mathématique, Faculté des sciences et génie, Université Laval, Pavillon Alexandre-Vachon, Québec, QC, Canada.

Leanna Cho (L)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Helen E Groves (HE)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Pierre-Philippe Piché-Renaud (PP)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Michael Kossov (M)

Department Laboratory Medicine and Pathobiology, Division of Medical Microbiology, The Hospital for Sick Children at University of Toronto, Toronto, ON, Canada.

Ikuho Kou (I)

Kaji Dental Clinic, Kobe, Hyogo, Japan.

Ilsu Jon (I)

Utsunomiya Kyoritsu Clinic, Utsunomiya, Tochigi, Japan.

Ana C Blanchard (AC)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Nao Matsuda (N)

Alpaca Child Dental Clinic, Hiroshima, Hiroshima, Japan.

Quenby Mahood (Q)

Hospital Library and Archives, Learning Institute, The Hospital for Sick Children at University of Toronto, Toronto, ON, Canada.

Anupma Wadhwa (A)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Ari Bitnun (A)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Shaun K Morris (SK)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Centre for Global Child Health and Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH